💊 › Jelito grube
I linia - pembrolizumab 10.2024 II linia CT: FOLFIRI + aflibercept 10.2024 II-V linia: Niwolumab+Ipilimumab 10.2024 II i kolejna linia CT: Triflurydyna z typiracylem +/- bev 01.2025

Leki z katalogu chemioterapii powiązane z tą kategorią:

Bevacizumab
C18C19C20
Capecitabine
C18C19C20
Carboplatin
C18C19C20
Cetuximab
C18C19C20
Cisplatinum
C18C19C20
Cyklophosphamidum
C18C19C20
Dacarbazinum
C18C19C20
Doxorubicinum
C18C19C20
Etoposidum
C18C19C20
Fluorouracilum
C18C19C20
Ifosfamidum
C18C19C20
Imatinibum
C18C19C20
Irinotecanum
C18C19C20
Lanreotidum
C18C19C20
Octreotidum
C18C19C20
Oxaliplatinum
C18C19C20
Panitumumab
C18C19C20
Sorafenib
C18C19C20
Sunitinib
C18C19C20
Temozolomidum
C18C19C20
Vincristinum
C18C19C20
Vinorelbinum
C18C19C20